ALEXANDR GULYAEV

Current Advances in Liver-Targeted Drug Delivery: Synthetic, Biological, and Biomimetic Platforms

Liver-targeted drug delivery offers opportunities to increase therapeutic exposure at sites of hepatic disease while limiting systemic toxicity; however, successful targeting requires more than preferential accumulation of a carrier within the liver. This narrative review critica...